[go: up one dir, main page]

FI954141L - Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa - Google Patents

Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa Download PDF

Info

Publication number
FI954141L
FI954141L FI954141A FI954141A FI954141L FI 954141 L FI954141 L FI 954141L FI 954141 A FI954141 A FI 954141A FI 954141 A FI954141 A FI 954141A FI 954141 L FI954141 L FI 954141L
Authority
FI
Finland
Prior art keywords
oxazoloquinolone
therapy
derivatives
preparation
oxazoloquinolone derivatives
Prior art date
Application number
FI954141A
Other languages
English (en)
Swedish (sv)
Other versions
FI954141A0 (fi
FI110945B (fi
Inventor
Samir Jegham
Jean Jacques Koenig
Frederic Puech
Philippe Burnier
Lydia Zard
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI954141A0 publication Critical patent/FI954141A0/fi
Publication of FI954141L publication Critical patent/FI954141L/fi
Application granted granted Critical
Publication of FI110945B publication Critical patent/FI110945B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Quinoline Compounds (AREA)
FI954141A 1994-09-05 1995-09-04 Oksatsolokinolinonijohdannaisia, niiden valmistus ja niiden käyttö terapiassa FI110945B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique
FR9410600 1994-09-05

Publications (3)

Publication Number Publication Date
FI954141A0 FI954141A0 (fi) 1995-09-04
FI954141L true FI954141L (fi) 1996-03-06
FI110945B FI110945B (fi) 2003-04-30

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954141A FI110945B (fi) 1994-09-05 1995-09-04 Oksatsolokinolinonijohdannaisia, niiden valmistus ja niiden käyttö terapiassa

Country Status (28)

Country Link
US (1) US5641785A (fi)
EP (1) EP0699680B1 (fi)
JP (1) JP4225585B2 (fi)
KR (1) KR100392523B1 (fi)
CN (1) CN1055472C (fi)
AT (1) ATE190311T1 (fi)
AU (1) AU687591B2 (fi)
CA (1) CA2157427C (fi)
CZ (1) CZ286128B6 (fi)
DE (1) DE69515402T2 (fi)
DK (1) DK0699680T3 (fi)
ES (1) ES2145886T3 (fi)
FI (1) FI110945B (fi)
FR (1) FR2724171B1 (fi)
GR (1) GR3033554T3 (fi)
HK (1) HK1013652A1 (fi)
HU (1) HU218587B (fi)
IL (1) IL115276A (fi)
NO (1) NO306617B1 (fi)
NZ (1) NZ272920A (fi)
PL (1) PL184412B1 (fi)
PT (1) PT699680E (fi)
RU (1) RU2141482C1 (fi)
SI (1) SI0699680T1 (fi)
SK (1) SK281867B6 (fi)
TW (1) TW356467B (fi)
UA (1) UA41916C2 (fi)
ZA (1) ZA957414B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
WO2005090309A1 (en) * 2004-03-12 2005-09-29 Wyeth 1,2-dihydroquinoline derivatives and method for using the same to treat hiv infection
WO2008112483A2 (en) * 2007-03-09 2008-09-18 Sanofi-Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) * 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−b酵素阻害活性を有する1,2,4−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
JP4225585B2 (ja) 2009-02-18
CN1055472C (zh) 2000-08-16
US5641785A (en) 1997-06-24
AU3041595A (en) 1996-03-21
DK0699680T3 (da) 2000-08-21
PT699680E (pt) 2000-08-31
NO953458D0 (no) 1995-09-04
PL184412B1 (pl) 2002-10-31
ATE190311T1 (de) 2000-03-15
SK281867B6 (sk) 2001-08-06
EP0699680B1 (fr) 2000-03-08
TW356467B (en) 1999-04-21
RU2141482C1 (ru) 1999-11-20
UA41916C2 (uk) 2001-10-15
HU9502578D0 (en) 1995-11-28
ZA957414B (en) 1996-04-15
ES2145886T3 (es) 2000-07-16
NO306617B1 (no) 1999-11-29
NO953458L (no) 1996-03-06
AU687591B2 (en) 1998-02-26
FR2724171A1 (fr) 1996-03-08
CN1128763A (zh) 1996-08-14
DE69515402D1 (de) 2000-04-13
CA2157427C (en) 2010-06-01
CZ286128B6 (cs) 2000-01-12
IL115276A0 (en) 1996-01-19
FI954141A0 (fi) 1995-09-04
IL115276A (en) 1998-12-06
KR100392523B1 (ko) 2003-11-12
CA2157427A1 (en) 1996-03-06
HU218587B (hu) 2000-10-28
JPH0899881A (ja) 1996-04-16
NZ272920A (en) 1998-03-25
KR960010648A (ko) 1996-04-20
DE69515402T2 (de) 2000-10-19
SI0699680T1 (en) 2000-10-31
SK108995A3 (en) 1996-06-05
GR3033554T3 (en) 2000-09-29
CZ226295A3 (en) 1996-03-13
PL310273A1 (en) 1996-03-18
HK1013652A1 (en) 1999-09-03
EP0699680A1 (fr) 1996-03-06
FI110945B (fi) 2003-04-30
FR2724171B1 (fr) 1997-01-03
HUT73435A (en) 1996-07-29

Similar Documents

Publication Publication Date Title
FI955235L (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
FI944600A0 (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
FI964311L (fi) Bifunktionaalinen proteiini, valmistus ja käyttö
EE9700039A (et) Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
EE9800459A (et) Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
EE200000037A (et) Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena
FI955140L (fi) Uusia kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeissä
FI950458L (fi) N-(3-aminopropyyli)-N-fenyyli-5,6,7,8-tetrahydronaftalen-2-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
IL99612A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their use in therapy
EE9700288A (et) Asatsükloalkaani derivaadid, nende valmistamine ja kasutamine ravis
EE9900218A (et) 1,4-diasabitsüklo[2.2.2]okt-2-üülmetüülbensoaadi derivaadid, nende valmistamine ja kasutamine raviks
EE04317B1 (et) 4-okso-3,5-dihüdro-4H-püridasino[4.5-b]indool-1-etaanamiidi derivaadid, nende valmistamine ja kasutamine raviks
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
FI940186A0 (fi) 9H-imidatso/1,2-a/bentsimidatsoli-3-asetamidijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine
EE9900135A (et) N-(2-bensotiasolüül)-1-piperidiinetaanamiini derivaadid, nende valmistamine ja kasutamine raviks
IL101617A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their application in therapy
FI954141L (fi) Oksatsolokinolonijohdannaiset, niiden valmistus ja niiden käyttö terapiassa
FI941963L (fi) Pyridiinijohdannaiset, niiden valmistus ja käyttö
FI956251A0 (fi) 1-okso-2-(fenyylisulfonyyliamino)pentyylipiperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI955386L (fi) 4-p-fluoribentsoyyli-1-piperidinyyli-propoksi-kromen-4-onijohdannaiset, niiden valmistus ja käyttö psykoosin ja skitsofrenian hoidossa
FI971317A (fi) Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS

MA Patent expired